Linking justice-involved individuals to HIV and opioid use disorder treatment
Official title: Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations
Funded at Yale University · NIH-10890124 · Data updated 2026-11-12
This study is looking to help people with HIV and opioid use disorder who are coming out of jail by testing two different ways to connect them to important healthcare services, so they can get the support they need to stay healthy after their release.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | September 30, 2020 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,926,146 |
| NIH project number | 5U01DA053039-05 |
| Project ID | NIH-10890124 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals recently released from prison or jail who have a history of opioid or injection drug use and are living with or at risk of HIV.
✕Less likely to help
Patients who are not involved in the criminal justice system or do not have a history of opioid use or HIV risk may not benefit from this research.
What this research studies
This research focuses on improving the management of HIV and opioid use disorder (OUD) for individuals involved in the criminal justice system. It aims to effectively screen and connect these individuals to community-based services for prevention and treatment. The study will compare two models of service delivery: Patient Navigation and Mobile Health Units, to determine which is more effective in linking recently released individuals to necessary healthcare services. Participants will be randomized to receive support for six months post-release, ensuring they have access to critical resources like PrEP for HIV prevention.
Why it matters
Potential benefit: If successful, this research could significantly enhance access to HIV and OUD treatment for justice-involved individuals, improving their health outcomes and reducing the risk of disease transmission.
How similar studies have gone: Previous research has shown success in linking similar populations to healthcare services, indicating that this approach has potential for effective outcomes.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Springer, Sandra Ann — Yale University
- Study coordinator: Springer, Sandra Ann
Related research
Other NIH-funded projects on the same topics.
-
Community care linking people leaving jail to HIV and opioid treatment
This project compares two ways to connect people leaving jail or prison who use opioids or are at risk for HIV to local HIV prevention/treatment and addiction services.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.